Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill (Zarzar, Williams, Pruette); North Carolina Department of Public Safety-Prisons, Raleigh (Sheitman). Paul S. Appelbaum, M.D., is editor of this column.
Psychiatr Serv. 2021 Apr 1;72(4):482-484. doi: 10.1176/appi.ps.202000845. Epub 2021 Feb 17.
People with serious mental illnesses increasingly are being treated in jails and prisons, and during incarceration are afforded a constitutional right to medical care. This right pertains to both general medical and mental illnesses and both acute and chronic conditions. However, incarcerated patients with treatment-resistant schizophrenia (TRS) often are not offered clozapine, the only medication for this debilitating illness approved by the U.S. Food and Drug Administration. In this column, the authors argue that incarcerated individuals with TRS have a statutory and constitutional right to treatment with clozapine.
患有严重精神疾病的人越来越多地在监狱中接受治疗，在监禁期间享有获得医疗保健的宪法权利。这项权利既涉及一般的医疗和精神疾病，也涉及急性和慢性疾病。然而，患有治疗抵抗性精神分裂症（TRS）的监禁患者通常无法获得氯氮平，这是唯一一种经美国食品和药物管理局批准用于治疗这种使人衰弱的疾病的药物。在这篇专栏文章中，作者认为，患有 TRS 的被监禁者有权获得氯氮平治疗。
